Opsidio
Bryn Mawr, US
Biotech
Founders & leadership
MD
Martin D. PhillipsExecutive Officer, Director
NW
Nicholas W. LukacsDirector
FW
Frank W. MarcouxDirector
AE
Alan E. CasnoffDirector
Reported raises · per SEC filings
Form D private placements$800.2KraisedOct 2017 · 4 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.